Literature DB >> 33223220

Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer.

Violante Di Donato1, Anna Di Pinto2, Andrea Giannini2, Giuseppe Caruso2, Ottavia D'Oria2, Federica Tomao2, Margherita Fischetti2, Giorgia Perniola2, Innocenza Palaia2, Ludovico Muzii2, Pierluigi Benedetti Panici2.   

Abstract

OBJECTIVE: The aim of this study was to assess the impact of surgical complexity on postoperative complications and mortality, according to patient's frailty (mFI) following surgery for ovarian cancer.
METHODS: Patients undergoing cytoreductive surgery for ovarian cancer from 2008 to 2018 were identified from our database. A surgical complexity score from 1 to 3 was used to assess the extent of surgery (simple to complex, respectively). mFI with 11 variables, based on mapping the Canadian Study of Health and Aging Frailty Index to the NSQIP comorbidities was evaluated. Data were analyzed using Fisher exact test, independent sample t-test, and logistic regression.
RESULTS: Of 263 patients identified, 33% reported at least one postoperative complication and 6% had severe complications. BMI ≥ 30 (p = 0.04) increased mFI (p = 0.04) and high-complexity surgery (p < 0.001) were independent predictors of severe complications (G3-G5). Patients with high frailty index score (mFI ≥ 3) who underwent intermediate or high-complexity surgery were at higher risk of severe complications ranging from 29.4% to 50.
CONCLUSIONS: The combined evaluation of mFI and surgical complexity expected may identify patients at higher risk for severe morbidity allowing to stratify patients who are less likely to tolerate a surgical extensive treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33223220     DOI: 10.1016/j.ygyno.2020.08.022

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Peri-operative blood management of Jehovah's Witnesses undergoing cytoreductive surgery for advanced ovarian cancer.

Authors:  Innocenza Palaia; Giuseppe Caruso; Violante Di Donato; Giorgia Perniola; Giancarlo Ferrazza; Enrico Panzini; Maria Scudo; Anna Di Pinto; Ludovico Muzii; Pierluigi Benedetti Panici
Journal:  Blood Transfus       Date:  2021-02-25       Impact factor: 3.443

Review 2.  Neuropsychiatric Disorders and Frailty in Older Adults over the Spectrum of Cancer: A Narrative Review.

Authors:  Mariya Muzyka; Luca Tagliafico; Gianluca Serafini; Ilaria Baiardini; Fulvio Braido; Alessio Nencioni; Fiammetta Monacelli
Journal:  Cancers (Basel)       Date:  2022-01-05       Impact factor: 6.639

3.  Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer.

Authors:  Qiaqia Li; Yinghong Deng; Wei Wei; Fan Yang; An Lin; Desheng Yao; Xiaofeng Zhu; Jundong Li
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244

4.  Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer.

Authors:  Myeong-Seon Kim; Seung Hun Baek; Joseph J Noh; Jung In Shim; Jun Hyeok Kang; Soo Young Jeong; Chel Hun Choi; Tae-Joong Kim; Jeong-Won Lee; Yoo-Young Lee
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

5.  Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis.

Authors:  Giuseppe Caruso; Innocenza Palaia; Giorgio Bogani; Federica Tomao; Giorgia Perniola; Pierluigi Benedetti Panici; Ludovico Muzii; Violante Di Donato
Journal:  J Gynecol Oncol       Date:  2022-07-06       Impact factor: 4.756

Review 6.  Association between Energy Balance-Related Factors and Clinical Outcomes in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis.

Authors:  Stephanie Stelten; Christelle Schofield; Yvonne A W Hartman; Pedro Lopez; Gemma G Kenter; Robert U Newton; Daniel A Galvão; Meeke Hoedjes; Dennis R Taaffe; Luc R C W van Lonkhuijzen; Carolyn McIntyre; Laurien M Buffart
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575

Review 7.  Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer.

Authors:  Carolina Maria Sassu; Innocenza Palaia; Serena Maria Boccia; Giuseppe Caruso; Giorgia Perniola; Federica Tomao; Violante Di Donato; Angela Musella; Ludovico Muzii
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.